Complications of immunosuppressive/immunomodulatory therapy in neurological diseases. - sprookjes - yvandenbroek - TriplyDB

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

http://www.wikidata.org/entity/Q37013065

about

Novel approaches and challenges to treatment of central nervous system viral infections Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.Neuroinfectious diseases: a crisis in neurology and a call for action.

P2860

Q26862449-BBAA958A-10EA-49D0-A637-AF9510C3132D Q30977483-76CBE677-7F41-4FF5-B66F-6DDCA9E95F6F Q37608252-31A654F2-C516-4298-A07D-F0165D7C3DF9

P2860

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

http://www.wikidata.org/entity/Q37013065

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@en

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@nl

type

label

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@en

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@nl

prefLabel

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@en

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@nl

P1433

Q37013065-80AF5E4B-7582-4D74-A10A-DEEF635886E7

P1476

Q37013065-5AD73E64-33E9-49B1-B00B-4D1F96575780

P2093

Q37013065-EC774845-CCC6-4CF4-845D-93F490E2C53D

Q37013065-F5B59B4F-C419-4363-98EC-939D9DBF308D

P2860

Q37013065-07C2FE71-E05F-48FB-809D-040F695CE8B5

Q37013065-0B6C10B7-C16D-4709-B6D5-DD01F2851092

Q37013065-29B71AE4-0543-4C33-AFAC-9F1969ED2DB9

Q37013065-2D3BB9AB-62BC-4FEF-8EFB-F66491FEC31A

Q37013065-3704097A-0AA2-4138-A102-095B2A2D90D1

Q37013065-40664F7C-87DB-4BED-A589-1DDA62E2BF31

Q37013065-4B5BA894-24CC-4E8B-8427-142ED7394117

Q37013065-4E94FF64-9D4E-43E0-B38B-9A5AA2E83B2D

Q37013065-531462DB-A6EB-44EA-BB41-6C08C0273136

Q37013065-581022B3-2179-40CA-AA83-CB3F75E0FC78

P2888

Q37013065-F5327F46-57B5-445D-9274-2D4A728FEFB4

P304

Q37013065-5539C8AE-9E90-4024-BE06-B7DD6F795164

P31

Q37013065-D4FCFD8F-3FBC-4BD6-A79C-4337FD37ACE4

P356

Q37013065-2FD41178-83D9-4927-836E-F59F7E407FCA

P433

Q37013065-621F0A29-6CA1-4DA9-A39F-CE20067C408D

P478

Q37013065-4C33C0D2-E22C-4865-873D-79970C12951A

P577

Q37013065-665B6617-6CF2-4242-9F93-48086C116AA5

P698

Q37013065-B698CCE3-D354-44DD-9A0F-1953FAFCD45A

P932

Q37013065-00A359F4-CF56-4B63-8DC1-8BCB31534820

P356

S11940-012-0172-Y

P1433

Current treatment options in neurology

P1476

Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

@en

P2093

Avindra Nath

http://www.w3.org/2001/XMLSchema#string

Joseph R Berger

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse effects of biologics: a network meta-analysis and Cochrane overview

Activities of various compounds against murine and primate polyomaviruses

Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Biology and treatment of primary central nervous system lymphoma.

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults.

Rituximab monotherapy for patients with recurrent primary CNS lymphoma.

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.

P2888

s11940-012-0172-y

P304

241-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11940-012-0172-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22528294

http://www.w3.org/2001/XMLSchema#string

P932

4910875

http://www.w3.org/2001/XMLSchema#string